Coronavirus Latest News
WHO nod is a major credibility boost for Beijing and Chinese pharmaceuticals
Backing from the World Health Organization is a major step towards the two most important goals of China’s vaccine diplomacy – establishing the reputation of Chinese pharmaceuticals and burnishing Beijing’s image as champion of the Global South.
Last Friday, the WHO listed BBIBP-CorV, the main vaccine from Chinese pharmaceutical giant Sinopharm, for emergency use. WHO emergency use listing is a prerequisite for participation in the Covax Facility, as well as distribution through other…
Read the original article at South China Morning Post